Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether extended prophylaxis with oral betrixaban can prevent blood clots in the leg and lung that sometime occur in patients hospitalized for an acute medical...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Portola Pharmaceuticals
NCT07015905 · Venous Thromboembolism (VTE)
NCT07140211 · Venous Thromboembolism (VTE), Postpartum
NCT07310693 · Venous Thromboembolism (VTE), Occult Cancer
NCT07288632 · Venous Thromboembolism (VTE), NSCLC (Advanced Non-small Cell Lung Cancer)
NCT06731673 · Venous Thromboembolism (VTE), Acute Myocardial Infarction With ST Segment Elevation, and more
Birmingham, Alabama
Bakersfield, California
Fresno, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions